Stay updated with breaking news from Ryanj Sullivan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ryan J. Sullivan, MD, discusses findings from a study investigating the effects of early circulating tumor DNA reduction on overall survival in patients with uveal melanoma treated with tebentafusp.
The results "support the need for prospective randomized clinical trials to definitively answer the important question about appropriate excision margins for T1a melanoma," the investigators write.
CAMBRIDGE, MA / ACCESSWIRE / March 14, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that two abstracts on mRNA-4157/V940
Lower response rates, worse survival seen in patients with detectable levels of the antipyretic